- Home
- MRNA vs AKAM Comparison
MRNA vs AKAM Comparison
Compare MRNA & AKAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- AKAM
- Stock Information
- Founded
- MRNA 2010
- AKAM 1998
- Country
- MRNA United States
- AKAM United States
- Employees
- MRNA N/A
- AKAM N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- AKAM Business Services
- Sector
- MRNA Health Care
- AKAM Consumer Discretionary
- Exchange
- MRNA Nasdaq
- AKAM Nasdaq
- Market Cap
- MRNA 9.2B
- AKAM 11.4B
- IPO Year
- MRNA 2018
- AKAM 1999
- Fundamental
- Price
- MRNA $24.45
- AKAM $84.29
- Analyst Decision
- MRNA Hold
- AKAM Hold
- Analyst Count
- MRNA 15
- AKAM 17
- Target Price
- MRNA $36.69
- AKAM $94.13
- AVG Volume (30 Days)
- MRNA 11.9M
- AKAM 2.2M
- Earning Date
- MRNA 11-06-2025
- AKAM 11-06-2025
- Dividend Yield
- MRNA N/A
- AKAM N/A
- EPS Growth
- MRNA N/A
- AKAM 0.97
- EPS
- MRNA N/A
- AKAM 3.41
- Revenue
- MRNA $2,232,000,000.00
- AKAM $4,133,202,000.00
- Revenue This Year
- MRNA N/A
- AKAM $6.69
- Revenue Next Year
- MRNA $10.38
- AKAM $5.12
- P/E Ratio
- MRNA N/A
- AKAM $24.53
- Revenue Growth
- MRNA N/A
- AKAM 4.21
- 52 Week Low
- MRNA $23.04
- AKAM $67.51
- 52 Week High
- MRNA $56.70
- AKAM $104.99
- Technical
- Relative Strength Index (RSI)
- MRNA 43.32
- AKAM 70.56
- Support Level
- MRNA $23.48
- AKAM $70.82
- Resistance Level
- MRNA $25.56
- AKAM $75.49
- Average True Range (ATR)
- MRNA 1.46
- AKAM 2.40
- MACD
- MRNA -0.32
- AKAM 0.61
- Stochastic Oscillator
- MRNA 15.89
- AKAM 88.35
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.